Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug
Background: COVID-19 disease caused by SARS-CoV-2 is lacking efficient medication although certain medications are used to relief its symptoms. Objectives: We tested an FDA-approved antiviral medication namely rilpivirine to find a drug against SARS-CoV-2. Methods: The inhibition of rilpivirine agai...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2021-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |